NEWS
Our Latest News
ARCHIMED MedTech sells orthopedic implants maker Citieffe to Poly Medicure, a leading global manufacturer of medical devices
Citieffe was the last investment in ARCHIMED’s MED I fund, now fully liquidated after generating 7.2 times investors’ money, or a 59 percent annual return over 11 years – the best performance of any 2014-vintage buyout fund.
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
November
26,
2024
ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing
November
8,
2024
ARCHIMED acquires FIM Medical, a leader in the vision, audio & respiratory medical devices market
October
15,
2024
368